Incyte (INCY) returns

Biotechnology · NASDAQ · Health Care

$120.39 +3.07% Close Oct 30, 2026 Live

Incyte returns over 10 years

$1,000 invested in Incyte ten years ago was worth $1,382 at the close on October 30, 2026, with dividends reinvested: an average return of 3.3% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.

INCY, $10,000 investedS&P 500 (SPY)
$20,000$40,000
20172019202120232025

Total return by period

With dividends reinvested, to the close on Oct 30, 2026. A year means 365 days.
PeriodTotal returnA year, on average$1,000 becameS&P 500 (SPY)
1 month -0.8% — $992.09 -0.9%
3 months -2.1% — $978.86 +2.1%
Year to date +21.9% — $1,219 +11.7%
1 year +30.0% — $1,300 +12.4%
3 years +130.8% +32.2% $2,308 +88.5%
5 years +79.7% +12.4% $1,797 +76.0%
10 years +38.2% +3.3% $1,382 +316.6%

Incyte return by calendar year

YearINCYS&P 500 (SPY)Difference
2026 to date +21.9% +11.7% +10.2%
2025 +43.0% +17.7% +25.3%
2024 +10.0% +24.9% -14.9%
2023 -21.8% +26.2% -48.0%
2022 +9.4% -18.2% +27.6%
2021 -15.6% +28.7% -44.4%
2020 -0.4% +18.4% -18.8%
2019 +37.3% +31.2% +6.1%
2018 -32.9% -4.6% -28.3%
2017 -5.5% +21.7% -27.2%
2016 -7.5% +12.0% -19.5%

Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.

See also: INCY financials · INCY valuation

No forecast, no recommendation. This page describes Incyte from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.